Custom Antibody Market by Service (Antibody Development, Production, Labelling), Type (Monoclonal, Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area (Oncology, Immunology), End User (Pharmaceutical Companies, CRO's), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The Custom Antibody Market size is projected to reach a CAGR of 9.2% from 2022 to 2028.
Custom antibody services are the procedure of customizing antibodies for applications in research and development. Custom antibody services are used by hospitals to treat immune system diseases such as cancer and other ailments. Custom antibody mainly used by hospitals to diagnose immune system disease, cancer, and other ailments.
An increase in research activity-especially in the life sciences industry-along with growing industry-academia collaboration are some of the factors that have supported long-term expansion for Custom Antibody Market.
North America accounted for the largest share in the custom antibody market. The large share of this region can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the increasing focus on developing antibody-based therapeutics.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 9.2% during the forecasting period, 2022-2028 |
Historical Data |
2019-2020 |
Forecast Years |
2022-2028 |
Base Year |
2021 |
Units Considered |
Revenue in USD billion and CAGR from 2022 to 2028 |
Report Segmentation |
service, type, source, research area, end user and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Merck Group, Abcam plc, BioLegend Inc., Agilent Technologies Inc., ProMab Biotechnologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., GenScript, Cell Signaling Technology, Inc., Rockland Immunochemicals |
Available Customization |
In addition to the market data for Custom Antibody Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Custom Antibody Market is segmented into service, type, source, research area, end user and region.